Mild synovitis develops early in OA progression, where synovial immune cells produce inflammatory mediators such as interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and activated metalloproteinases (MMPs), further accelerating cartilage degradation (69). The gene discussed is TNF; the disease is synovitis.